Suprax
Product Images NDC 70934-079

2 FDA label images from Denton Pharma, Inc. Dba Northwind Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Suprax (NDC 70934-079). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cefixime Usp (364fe09d 9218 49ee 810a 88c8adb2ccf7 01)

Cefixime Usp (364fe09d 9218 49ee 810a 88c8adb2ccf7 01)
Chemical structure diagram of the active ingredient in SUPRAX, depicting the molecular arrangement including an amine group, carboxyl groups, sulfur-containing rings, and a trihydrate component indicated by 3H2O.*
FDA Label Image

70934 079 01 Rev B 09 19

70934 079 01   Rev B 09 19
Label of Suparax Cefixime Capsules, 400mg, containing 1 capsule per package. The label includes the NDC 70934-079-01 and instructions to use the medication as prescribed. It shows storage conditions, manufacturer information, and recycling details. The label is marked Rx Only and includes safety warnings and expiration date placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.